GlassScriptPhysician profile
Rabina Sippy
NPI 1982369633
$732.74
in general payments reported to CMS, 2019-2025
15 companies · $733 in 2025
The $733 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $106.19 | 2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $99.03 | 2025 | Trelegy Ellipta |
| Lilly USA, LLC | $84.17 | 2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $70.10 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.63 | 2025 | Caplyta |
| Amgen INC. | $49.46 | 2025 | Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $45.68 | 2025 | Rexulti |
| Dexcom, INC. | $40.41 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $37.91 | 2025 | Capvaxive, Gardasil 9 |
| Pfizer INC. | $35.44 | 2025 | |
| Abbott Laboratories | $25.19 | 2025 | Freestyle Libre 3 |
| Corium, LLC | $24.57 | 2025 | Azstarys |
| Exact Sciences Corporation | $23.62 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.52 | 2025 | Xifaxan |
| Insulet Corporation | $17.82 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabina Sippy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.